home / stock / bfra / bfra news

BFRA News and Press, Biofrontera AG From 06/22/21

Stock Information
Company Name: Biofrontera AG
Stock Symbol: BFRA
Market: NASDAQ
Menu
BFRA BFRA Quote BFRA Short BFRA News BFRA Articles BFRA Message Board
Get BFRA Alerts

News, Short Squeeze, Breakout and More Instantly...
BFRA - Biofrontera provides update on clinical developments

Leverkusen, Germany, June 22, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today provides an update on its clinical developments. In February and March 2021, the Com...
BFRA - Biofrontera reports prelim product sales revenue growth of 108% in May

For May 2021, Biofrontera ([[BFRA]] +1.0%) reported prelim revenue from product sales of €2.44M compared to €1.17M in year ago quarter.Out of the total, revenues from product sales in the U.S. increased 174% while Germany revenues dropped 21%; rest of Europe ...

BFRA - Biofrontera reports preliminary revenue for the month of May 2021

Leverkusen, Germany, June 07, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of May 2021. The Companyȁ...

BFRA - Reata Pharmaceuticals, LifeMD leads healthcare gainers; Onconova Therapeutics, Iovance Biotherapeutics among major losers

Gainers: Reata Pharmaceuticals (RETA) +20%, LifeMD (LFMD) +13%, Eloxx Pharmaceuticals (ELOX) +10%, Cerecor (CERC) +10%, Biofrontera (BFRA) +7%.Losers: Onconova Therapeutics (ONTX) -23%, Iovance Biotherapeutics (IOVA) -18%,&...
BFRA - Biofrontera reports Q1 2021 financial results

Leverkusen, Germany, May 11, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the first quarter ended March 31, 2021. Q1 2021 ...

BFRA - Stealth BioTherapeutics, Biofrontera leads healthcare gainers; Regional Health Properties, VYNE Therapeutics among major losers

Gainers: Stealth BioTherapeutics (MITO) +45%, Biofrontera (BFRA) +18%, BioCryst Pharmaceuticals (BCRX) +15%, Orgenesis (ORGS) +12%, GT Biopharma (GTBP) +4%.Losers: Regional Health Properties (RHE) -24%, VYNE Therapeutics (VYNE) ...

BFRA - Biofrontera trades in green on higher prelim revenue for April

Biofrontera (BFRA) trades 5.9% higher premarket after estimating April product sales revenue to be ~€2.49M compared to €0.49M in same month last year.Prelim product sales revenues in U.S. increased 447% to €1.82M; Germany revenues rose 208% t...
BFRA - Biofrontera reports preliminary revenue for the month of April 2021

Leverkusen, Germany, May 06, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of April 2021. The Company ...

BFRA - Biofrontera AG: First quarter conference call to be held on May 12, 2021

Leverkusen, Germany, May 03, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its financial results for the first quarter 2021 on Tuesday, May 11, 2021...

BFRA - Biofrontera AG (BFRA) CEO Hermann Lübbert on Q4 2020 Results - Earnings Call Transcript

Biofrontera AG (BFRA) Q4 2020 Earnings Conference Call April 13, 2021 08:00 AM ET Company Participants Pamela Keck - Head, Investor Relations Hermann Lübbert - Chief Executive Officer Ludwig Lutter - Chief Financial Officer Conference Call Participants Bruce Jackson - The Benchmark Compa...
Previous 10 Next 10